We are live on
!
Find out more
BFA
BlackRock Fund Advisors Portfolio holdings
AUM
$542B
1-Year Est. Return
18.13%
This Fund
S&P 500
This Quarter
Est. Return
+0.29%
1 Year Est. Return
+18.13%
3 Year Est. Return
+41.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$417B
AUM Growth
-$1.66B
(-0.4%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
0.46%
Top 10 Holdings %
Top 10 Hldgs %
9.45%
Holding
4,011
New
140
Increased
1,618
Reduced
1,966
Closed
139
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Germany ETF
EWG
|
+$739M |
| 2 |
iShare MSCI Eurozone ETF
EZU
|
+$723M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$662M |
| 4 |
iShares MSCI Japan ETF
EWJ
|
+$452M |
| 5 |
Jazz Pharmaceuticals
JAZZ
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LO
LORILLARD INC COM STK
LO
|
+$553M |
| 2 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$381M |
| 3 |
Qorvo
QRVO
|
+$377M |
| 4 |
TEG
INTEGRYS ENERGY GROUP INC COM (USA)
TEG
|
+$319M |
| 5 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.1% |
| 2 | Financials | 12.85% |
| 3 | Technology | 12.68% |
| 4 | Industrials | 10.63% |
| 5 | Consumer Discretionary | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Cerus
CERS
$579M
| $19.5M | ﹤0.01% |
3,755,677
-56,822
| -1% | -$269K |
|
|
SCLN
2127
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $19.5M | ﹤0.01% |
1,984,500
-122,432
| -6% | -$1.12M |
|
2128
WSFS Financial
WSFS
$4.1B
| $19.4M | ﹤0.01% |
709,838
-17,899
| -2% | -$455K |
|
|
DX
2129
Dynex Capital
DX
$3.18B
| $19.3M | ﹤0.01% |
846,325
-64,829
| -7% | -$1.54M |
|
|
ENIA
2130
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
| $19.3M | ﹤0.01% |
2,265,959
-27,823
| -1% | -$257K |
|
2131
Infosys
INFY
$48.4B
| $19.3M | ﹤0.01% |
2,432,286
+588,550
| +32% | +$4.78M |
|
2132
Greenlight Captial
GLRE
$552M
| $19.3M | ﹤0.01% |
660,290
-65,644
| -9% | -$2M |
|
|
LABL
2133
DELISTED
Multi-Color Corp
LABL
| $19.3M | ﹤0.01% |
301,374
-40,525
| -12% | -$2.59M |
|
2134
U-Haul Holding Co
UHAL
$13.9B
| $19.2M | ﹤0.01% |
588,050
+11,610
| +2% | +$379K |
|
|
GLUU
2135
DELISTED
Glu Mobile Inc.
GLUU
| $19.2M | ﹤0.01% |
3,094,496
+566,233
| +22% | +$3.47M |
|
|
SPWR
2136
DELISTED
SunPower Corporation Common Stock
SPWR
| $19.2M | ﹤0.01% |
1,031,461
+147,962
| +17% | +$3.11M |
|
2137
National Healthcare
NHC
$3.58B
| $19.1M | ﹤0.01% |
294,531
-2,636
| -0.9% | -$167K |
|
|
NTK
2138
DELISTED
NORTEK INC COM NEW (DE)
NTK
| $19.1M | ﹤0.01% |
230,190
-4,975
| -2% | -$421K |
|
|
CJES
2139
DELISTED
C&J ENERGY SVCS LTD
CJES
| $19.1M | ﹤0.01% |
+1,448,106
| New | +$21.4M |
|
2140
Powell Industries
POWL
$7.63B
| $19M | ﹤0.01% |
1,624,743
-58,716
| -3% | -$701K |
|
2141
Cooper-Standard Automotive
CPS
$514M
| $19M | ﹤0.01% |
309,837
-28,671
| -8% | -$1.79M |
|
2142
Usana Health Sciences
USNA
$409M
| $19M | ﹤0.01% |
277,846
-22,194
| -7% | -$1.41M |
|
|
ASEI
2143
DELISTED
AMER SCIENCE & ENGR INC.
ASEI
| $19M | ﹤0.01% |
433,256
-17,069
| -4% | -$738K |
|
2144
OneMain Financial
OMF
$7.32B
| $19M | ﹤0.01% |
413,242
-198,525
| -32% | -$9.63M |
|
|
GLOG
2145
DELISTED
GASLOG LTD
GLOG
| $18.9M | ﹤0.01% |
947,898
-97,922
| -9% | -$2.07M |
|
|
GWPH
2146
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $18.9M | ﹤0.01% |
153,470
+6,488
| +4% | +$736K |
|
|
PVA
2147
DELISTED
PENN VIRGINIA CORP
PVA
| $18.8M | ﹤0.01% |
4,300,708
+220,689
| +5% | +$1.25M |
|
|
PETX
2148
DELISTED
Aratana Therapeutics, Inc.
PETX
| $18.7M | ﹤0.01% |
1,237,439
-7,239
| -0.6% | -$105K |
|
|
EBSB
2149
DELISTED
Meridian Bancorp, Inc.
EBSB
| $18.7M | ﹤0.01% |
1,394,284
+822,977
| +144% | +$10.7M |
|
|
OMED
2150
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $18.6M | ﹤0.01% |
827,409
+100,028
| +14% | +$2.47M |
|
Similar funds
BIT
BG
BA
BIM
BJ
IC
EAM
MFS
BlackRock Fund Advisors's Q2 2015 Portfolio in Review
As of Q2 2015, BlackRock Fund Advisors held 4,011 positions worth $417B, down 0.4% from $419B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
BlackRock Fund Advisors's Q2 2015 filing shows 140 new, 1,618 increased, 1,966 reduced and 139 closed positions. Its largest new stake was Jazz Pharmaceuticals: 1,516,810 shares worth $267M. The largest sale was LORILLARD INC COM STK, an estimated $553M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Financials and Technology.
- BlackRock Fund Advisors's largest Q2 2015 buy was Jazz Pharmaceuticals: 1,516,810 shares worth $267M.
- BlackRock Fund Advisors added most to iShares MSCI Germany ETF in Q2 2015, an estimated $739M increase.
- BlackRock Fund Advisors's biggest Q2 2015 reduction was Qorvo, cutting an estimated $377M.
- BlackRock Fund Advisors fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $553M.
- BlackRock Fund Advisors's ten largest holdings make up 9.5% of its $417B portfolio in Q2 2015.
- BlackRock Fund Advisors opened 140 new positions and closed 139 in Q2 2015.
- BlackRock Fund Advisors's portfolio value fell 0.4% quarter-over-quarter to $417B.
Based on BlackRock Fund Advisors's 13F filing for Q2 2015, filed 7 Aug 2015.